Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHA:600488)

Market Cap	4.55B
Revenue (ttm)	3.14B
Net Income (ttm)	133.49M
Shares Out	1.09B
EPS (ttm)	0.12
PE Ratio	34.18
Forward PE	n/a
Dividend	0.10 (2.40%)
Ex-Dividend Date	Jun 14, 2024

Volume	6,326,556
Average Volume	6,737,071
Open	4.110
Previous Close	4.090
Day's Range	4.090 - 4.180
52-Week Range	3.320 - 4.840
Beta	0.31
RSI	58.73
Earnings Date	Apr 29, 2025

About SHA:600488

Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research and development, production, and sales of corticosteroids, amino acid active pharmaceutical ingredients (APIs), and preparations in China. Its primary products comprising corticosteroid raw materials, such as dexamethasone, prednisone, methylprednisolone, and betamethasone product series. The company provides amino acid raw materials, as well as dosage forms, including injections, ointments, creams, hard capsules, pills, freeze-dried powder injections, inhalation preparations, an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1939
• Employees: 2,884
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600488

Financial Performance

In 2024, SHA:600488's revenue was 3.22 billion, a decrease of -15.00% compared to the previous year's 3.78 billion. Earnings were 133.45 million, an increase of 14.01%.